Biodesix, Inc.
BDSX
$0.8622
$0.01221.44%
| 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | |
|---|---|---|---|---|---|
| Net Income | 6.31% | 19.08% | 27.21% | 55.06% | 20.07% |
| Total Depreciation and Amortization | 20.42% | -0.42% | -8.09% | -20.72% | -25.54% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -52.40% | -3.55% | -0.37% | -63.06% | -15.25% |
| Change in Net Operating Assets | -269.39% | -214.71% | -222.71% | -1,304.65% | 181.15% |
| Cash from Operations | -178.04% | -2,081.96% | -99.21% | -2.80% | 62.85% |
| Capital Expenditure | 96.05% | 69.99% | 96.95% | -54.61% | -651.87% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -34.15% | -29.09% | -30.00% | 70.18% | -7.89% |
| Cash from Investing | 95.14% | 69.14% | 96.46% | -51.03% | -621.84% |
| Total Debt Issued | -- | -- | -- | -66.67% | -- |
| Total Debt Repaid | -8.33% | 0.00% | -8.33% | 99.94% | 99.40% |
| Issuance of Common Stock | -97.72% | 67,806.17% | 113.62% | -69.27% | 661.49% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 94.17% | -54.06% | 96.26% | 82.96% | -47.32% |
| Cash from Financing | -98.82% | 2,301.55% | 132.67% | -48.08% | 636.51% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -544.80% | 490.69% | 16.95% | -76.91% | 118.13% |
